In Depth 3 Jul 2025 Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer …two doses of the vaccine, one week apart. The researchers found that in these mice, metabolic changes occurred in the CAR-T cells that increased their production of interferon gamma –… July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 7 Mar 2017 A New Transatlantic Partnership takes on Antibiotic Resistance …tuberculosis strains by inhibiting the transcriptional regulator EthR, which inhibits the metabolic activation of the established tuberculosis drug ethionamide (ETH). The preclinical candidate has been shown to dramatically increase the… March 7, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Interview 24 May 2018 Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry …sugar to produce the same amount of colorant,” he explained. Blache didn’t delve too deeply into the details of the company’s technological process, but essentially the process involves engineering metabolic… May 24, 2018 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2020 Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and respiratory diseases. RNA interference, or RNAi, is a relatively new field of medicine in which… March 26, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2022 Trial and new drug for Tourette Syndrome after $250M after funding round completed …in the study were headache, fatigue, somnolence, insomnia and restlessness. Patients in the trial did not have observable evidence of adverse movement or metabolic side effects commonly reported with antipsychotic… November 3, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
More News! 9 Mar 2017 There’s a New Target for Anti-Aging Therapies …research has revealed that the rising number of senescent cells, which appear during normal ageing, contributes to many age-related diseases. In a new study by Ana O’Loghlen and collegues, integrin-ß3… March 9, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Startup Scout 27 Apr 2018 This Portuguese Biotech is Developing a Faster Antimicrobial Susceptibility Test …date, the company has raised €2.7M in grant funding to develop its technology, which uses flow cytometry to detect microbial cell lesions or metabolic changes in bacteria in response to… April 27, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 20 Nov 2024 Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024 Hypoparathyroidism is a rare condition in which the body produces abnormally low levels of a hormone called the parathyroid hormone (PTH), which is key to regulating and maintaining a balance… November 20, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2022 Study of drug to treat porphyria disorders initiated by Disc Medicine …due to deficiencies of certain types of enzymes essential to the synthesis of hemoglobin. Hematologic diseases U.S.-based Disc Medicine focuses its work on discovering and developing novel therapeutic candidates for… August 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email